本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Esperion Therapeutics Inc.

3.14
-0.0300-0.95%
盤後3.140.00000.00%19:58 EST
成交量:429.60萬
成交額:1,345.93萬
市值:7.51億
市盈率:-5.86
高:3.18
開:3.18
低:3.10
收:3.17
52周最高:4.18
52周最低:0.6925
股本:2.39億
流通股本:2.37億
量比:0.80
換手率:1.81%
股息:- -
股息率:- -
每股收益(TTM):-0.5358
每股收益(LYR):-0.2764
淨資產收益率:97.76%
總資產收益率:-5.42%
市淨率:-1.66
市盈率(LYR):-11.36

資料載入中...

2024/01/25

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/22

重要事件披露

Form 8-K - Current report
2024/01/19

重要事件披露

Form 8-K - Current report
2024/01/18

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/11

重要事件披露

Form 8-K - Current report
2024/01/03

重要事件披露

Form 8-K - Current report
2023/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/07

重要事件披露

Form 8-K - Current report
2023/10/05

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/09/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/30

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/28

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/24

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/08/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/01

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/08/01

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/01

重要事件披露

Form 8-K - Current report
2023/07/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/26

重要事件披露

Form 8-K - Current report
2023/06/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities